Regulation of the function of eosinophils and basophils

Critical Reviews in Immunology

Volumn 17, Issue 3-4, 1997, Pages 325-352

  Hirai, Koichi ^a   Miyamasu, Misato ^a   Takaishi, Toshiaki ^a   Morita, Yutaka ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Adhesion molecules; Glucocorticoid; GM CSF; IL 3; IL 5; Tyrosine phosphorylation

Indexed keywords

CHEMOKINE; CYCLOSPORIN A; CYTOKINE; GLUCOCORTICOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON; INTERLEUKIN 3; INTERLEUKIN 5; LIPOPOLYSACCHARIDE; NERVE GROWTH FACTOR; NITRIC OXIDE; SOMATOMEDIN; STEM CELL FACTOR; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; BASOPHIL; CELL FUNCTION; CELL SURVIVAL; CELL TYPE; CHEMOTAXIS; CROSS LINKING; EOSINOPHIL; INFLAMMATORY CELL; MEDIATOR RELEASE; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVIEW; STEM CELL;

EID: 0030971668     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevimmunol.v17.i3-4.40     Document Type: Review

References (261)

1. Gleich, G. J., Adolphson, C. R., and Leiferman, K. M., The biology of the eosinophilic leukocyte, Annu. Rev. Med., 44, 85, 1993.
2. Weller, P. F., The immunobiology of eosinophils, N. Engl. J. Med., 324, 1110, 1991.
3. Lee, T., Lenihan, D. J., Malone, B., Roddy, L. L., and Wasserman, S. I., Increased biosynthesis of platelet-activating factor in activated human eosinophils, J. Biol. Chem., 259, 5526, 1984.
4. Dolovich, J., Hargreave, F. E., Chalmers, R., Shier, K. J., Gauldie, J., and Bienenstock, J., Late cutaneous allergic responses in isolated IgE-dependent reactions, J. Allergy Clin. Immunol., 52, 38, 1973.
5. Lemanske, R. F., Jr. and Kaliner, M., Late-phase IgE-mediated reactions, J. Clin. Immunol., 8, 1, 1988.
6. Durham, S. R. and Kay, A. B., Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions, Clin. Allergy, 15, 411, 1985.
7. Henocq, E. and Vargaftig, B. B., Skin eosinophilia in atopic patients, J. Allergy Clin. Immunol., 81, 691, 1988.
8. Togias, A., Naclerio, R. M., Proud, D., Pipkorn, U., Bascom, R., Iliopoulos, O., Kagey Sobotka, A., Norman, P. S., and Lichtenstein, L. M., Studies on the allergic and nonallergic nasal inflammation, J. Allergy Clin. Immunol., 81, 782, 1988.
9. Diaz, P., Gonzalez, M. C., Galleguillos, F. R., Ancic, P., Cromwell, O., Shepherd, D., Durham, S. R., Gleich, G. J., and Kay, A. B., Leukocytes and mediators in brochoalveolar lavage during allergen-induced late-phase asthmatic reactions, Am. Rev. Respir. Dis., 139, 1383, 1989.
10. Wegner, C. D., Gundel, R. H., Reilly, P., Haynes, N., Letts, L. G., and Rothlein, R., Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma, Science, 247, 456, 1990.
11. Schroeder, J. T., Kagey Sobotka, A., and Lichtenstein, L. M., The role of the basophil in allergic inflammation, Allergy, 50, 463, 1995.
12. Charlesworth, E. N., Hood, A. F., Soter, N. A., Kagey Sobotka, A., Norman, P. S., and Lichtenstein, L. M., Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration, J. Clin. Invest., 83, 1519, 1989.
13. Iliopoulos, O., Baroody, F. M., Naclerio, R. M., Bochner, B. S., Kagey Sobotka, A., and Lichtenstein, L. M., Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils, J. Immunol., 148, 2223, 1992.
14. Guo, C. B., Liu, M. C., Galli, S. J., Bochner, B. S., Kagey Sobotka, A., and Lichtenstein, L. M., Identification of IgE-bearing cells in the late-phase response to antigen in the lung as basophils, Am. J. Respir. Cell. Mol. Biol., 10, 384, 1994.
15. Naclerio, R. M., Proud, D., Togias, A. G., Adkinson, N. F., Jr., Meyers, D. A., Kagey Sobotka, A., Plaut, M., Norman, P. S., and Lichtenstein, L. M., Inflammatory mediators in late antigen-induced rhinitis, N. Engl. J. Med., 313, 65, 1985.
16. Valent, P. and Bettelheim, P., Cell surface structures on human basophils and mast cells: biochemical and functional characterization, Adv. Immunol., 52, 333, 1992.
17. Ackerman, S. J., Kephart, G. M., Habermann, T. M., Greipp, P. R., and Gleich, G. J., Localization of eosinophil granule major basic protein in human basophils, J. Exp. Med., 158, 946, 1983.
18. Ackerman, S. J., Weil, G. J., and Gleich, G. J., Formation of Charcot-Leyden crystals by human basophils, J. Exp. Med., 155, 1597, 1982.
19. Denburg, J. A., Telizyn, S., Messner, H., Lim, B., Jamal, N., Ackerman, S. J., Gleich, G. J., and Bienenstock, J., Heterogeneity of human peripheral blood eosinophil-type colonies: evidence for a common basophil-eosinophil progenitor, Blood, 66, 312, 1985.
20. Leary, A. G. and Ogawa, M., Identification of pure and mixed basophil colonies in culture of human peripheral blood and marrow cells, Blood, 64, 78, 1984.
21. Weil, S. C. and Hrisinko, M. A., A hybrid eosinophilic-basophilic granulocyte in chronic granulocytic leukemia, Am. J. Clin. Pathol., 87, 66, 1987.
22. Bitter, M. A., Le Beau, M. M., Larson, R. A., Rosner, M. C., Golomb, H. M., Rowley, J. D., and Vardiman, J. W., A morphologic and cytochemical study of acute myelomonocytic leukemia with abnormal marrow eosinophils associated with inv(16) (p13q22), Am. J. Clin. Pathol., 81, 733, 1984.
23. Gounni, A. S., Lamkhioued, B., Ochiai, K., Tanaka, Y., Delaporte, E., Capron, A., Kinet, J. P., and Capron, M., High-affinity IgE receptor on eosinophils is involved in defence against parasites, Nature, 367, 183, 1994.
24. Winqvist, I., Olofsson, T., Olsson, I., Persson, A. M., and Hallberg, T., Altered density, metabolism and surface receptors of eosinophils in eosinophilia, Immunology, 47, 531, 1982.
25. Prin, L., Capron, M., Tonnel, A. B., Bletry, O., and Capron, A., Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia, Int. Arch. Allergy Appl. Immunol., 72, 336, 1983.
26. Owen, W. F., Rothenberg, M. E., Petersen, J., Weller, P. F., Silberstein, D., Sheffer, A. L., Stevens, R. L., Soberman, R. J., and Austen, K. F., Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome, J. Exp. Med., 170, 343, 1989.
27. Tai, P. C. and Spry, C. J., Studies on blood eosinophils. I. Patients with a transient eosinophilia, Clin. Exp. Immunol., 24, 415, 1976.
28. Kato, M., Liu, M. C., Stealey, B. A., Friedman, B., Lichtenstein, L. M., Permutt, S., and Schleimer, R. P., Production of granulocyte/macrophage colony-stimulating factor in human airways during allergen-induced late-phase reactions in atopic subjects, Lymphokine Cytokine Res., 11, 287, 1992.
29. Ohnishi, T., Kita, H., Weiler, D., Sur, S., Sedgwick, J. B., Calhoun, W. J., Busse, W. W., Abrams, J. S., and Gleich, G. J., IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction, Am. Rev. Respir. Dis., 147, 901, 1993.
30. Woolley, K. L., Adelroth, E., Woolley, M. J., Ellis, R., Jordana, M., and O'Byrne, P. M., Granulocyte-macrophage colony-stimulating factor, eosinophils and eosinophil cationic protein in subjects with and without mild, stable, atopic asthma, Eur. Respir. J., 7, 1576, 1994.
31. Walker, C., Bauer, W., Braun, R. K., Menz, G., Braun, P., Schwarz, F., Hansel, T. T., and Villiger, B., Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am. J. Respir. Crit. Care Med., 150, 1038, 1994.
32. Sim, T. C., Grant, J. A., Hilsmeier, K. A., Fukuda, Y., and Alam, R., Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge, Am. J. Respir. Crit. Care Med., 149, 339, 1994.
33. Broide, D. H., Lotz, M., Cuomo, A. J., Coburn, D. A., Federman, E. C., and Wasserman, S. I., Cytokines in symptomatic asthma airways, J. Allergy Clin. Immunol., 89, 958, 1992.
34. Owen, W. F., Jr., Petersen, J., Sheff, D. M., Folkerth, R. D., Anderson, R. J., Corson, J. M., Sheffer, A. L., and Austen, K. F., Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome, Proc. Natl. Acad. Sci. U.S.A., 87, 8647, 1990.
35. Butterfield, J. H., Leiferman, K. M., Abrams, J., Silver, J. E., Bower, J., Gonchoroff, N., and Gleich, G. J., Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia, Blood, 79, 688, 1992.
36. Kay, A. B., Ying, S., Varney, V., Gaga, M., Durham, S. R., Moqbel, R., Wardlaw, A. J., and Hamid, Q., Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/ macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects, J. Exp. Med., 173, 775, 1991.
37. Broide, D. H. and Firestein, G. S., Endobronchial allergen challenge in asthma. Demonstration of cellular source of granulocyte macrophage colony-stimulating factor by in situ hybridization, J. Clin. Invest., 88, 1048, 1991.
38. Ohtoshi, T., Tsuda, T., Vancheri, C., Abrams, J. S., Gauldie, J., Dolovich, J., Denburg, J. A., and Jordana, M., Human upper airway epithelial cell-derived granulocyte-macrophage colony-stimulating factor induces histamine-containing cell differentiation of human progenitor cells, Int. Arch. Allergy Appl. Immunol., 95, 376, 1991.
39. Standiford, T. J., Kunkel, S. L., Basha, M. A., Chensue, S. W., Lynch, J. P. D., Toews, G. B., Westwick, J., and Strieter, R. M., Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung, J. Clin. Invest., 86, 1945, 1990.
40. Stellato, C., Beck, L. A., Gorgone, G. A., Proud, D., Schall, T. J., Ono, S. J., Lichtenstein, L. M., and Schleimer, R. P., Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids, J. Immunol., 155, 410, 1995.
41. Bradding, P., Feather, I. H., Wilson, S., Bardin, P. G., Heusser, C. H., Holgate, S. T., and Howarth, P. H., Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation, J. Immunol., 151, 3853, 1993.
42. Bradding, P., Roberts, J. A., Britten, K. M., Montefort, S., Djukanovic, R., Mueller, R., Heusser, C. H., Howarth, P. H., and Holgate, S. T., Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines, Am. J. Respir. Cell. Mol. Biol., 10, 471, 1994.
43. Walker, C., Virchow, J. C., Jr., Bruijnzeel, P. L., and Blaser, K., T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma, J. Immunol., 146, 1829, 1991.
44. Lopez, A. F., Eglinton, J. M., Gillis, D., Park, L. S., Clark, S., and Vadas, M. A., Reciprocal inhibition of binding between interleukin 3 and granulocyte-macrophage colony-stimulating factor to human eosinophils, Proc. Natl. Acad. Sci. U.S.A., 86, 7022, 1989.
45. Chihara, J., Plumas, J., Gruart, V., Tavernier, J., Prin, L., Capron, A., and Capron, M., Characterization of a receptor for interleukin 5 on human eosinophils: variable expression and induction by granulocyte/macrophage colony-stimulating factor, J. Exp. Med., 172, 1347, 1990.
46. Valent, P., Besemer, J., Muhm, M., Majdic, O., Lechner, K., and Bettelheim, P., Interleukin 3 activates human blood basophils via high-affinity binding sites, Proc. Natl. Acad. Sci. U.S.A., 86, 5542, 1989.
47. Lopez, A. F., Eglinton, J. M., Lyons, A. B., Tapley, P. M., To, L. B., Park, L. S., Clark, S. C., and Vadas, M. A., Human interleukin-3 inhibits the binding of granulocyte-macrophage colony-stimulating factor and interleukin-5 to basophils and strongly enhances their functional activity, J. Cell. Physiol., 145, 69, 1990.
48. Lopez, A. F., Lyons, A. B., Eglinton, J. M., Park, L. S., To, L. B., Clark, S. C., and Vadas, M. A., Specific binding of human interleukin-3 and granulocyte-macrophage colony-stimulating factor to human basophils, J. Allergy Clin. Immunol., 85, 99, 1990.
49. Lopez, A. F., Vadas, M. A., Woodcock, J. M., Milton, S. E., Lewis, A., Elliott, M. J., Gillis, D., Ireland, R., Olwell, E., and Park, L. S., Interleukin-5, interleukin-3, and granulocyte-macrophage colony-stimulating factor cross-compete for binding to cell surface receptors on human eosinophils, J. Biol. Chem., 266, 24741, 1991.
50. Miyajima, A., Molecular structure of the IL-3, GM-CSF and IL-5 receptors, Int. J. Cell. Cloning, 10, 126, 1992.
51. Lopez, A. F., Elliott, M. J., Woodcock, J., and Vadas, M. A., GM-CSF, IL-3 and IL-5: cross-competition on human haemopoietic cells, Immunol. Today, 13, 495, 1992.
52. Takatsu, K., Tominaga, A., Harada, N., Mita, S., Matsumoto, M., Takahashi, T., Kikuchi, Y., and Yamaguchi, N., T cell-replacing factor (TRF)/ interleukin 5 (IL-5): molecular and functional properties, Immunol. Rev., 102, 107, 1988.
53. Sher, A., Coffman, R. L., Hieny, S., Scott, P., and Cheever, A. W., Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni, Proc. Natl. Acad. Sci. U.S.A., 87, 61, 1990.
54. Tominaga, A., Takaki, S., Koyama, N., Katoh, S., Matsumoto, R., Migita, M., Hitoshi, Y., Hosoya, Y., Yamauchi, S., Kanai, Y., Miyazaki, J.-I., Usuki, G., Yamamura, K.-I., and Takatsu, K., Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production, J. Exp. Med., 173, 429, 1991.
55. Saito, H., Hatake, K., Dvorak, A. M., Leiferman, K. M., Donnenberg, A. D., Arai, N., Ishizaka, K., and Ishizaka, T., Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins, Proc. Natl. Acad. Sci. U.S.A., 85, 2288, 1988.
56. Dvorak, A. M., Saito, H., Estrella, P., Kissell, S., Arai, N., and Ishizaka, T., Ultrastructure of eosinophils and basophils stimulated to develop in human cord blood mononuclear cell cultures containing recombinant human interleukin-5 or interleukin-3, Lab. Invest., 61, 116, 1989.
57. Clutterbuck, E. J., Hirst, E. M., and Sanderson, C. J., Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. Blood, 73, 1504, 1989.
58. Pazdrak, K., Schreiber, D., Forsythe, P., Justement, L., and Alam, R., The intracellular signal transduction mechanism of interleukin 5 in eosinophils: the involvement of lyn tyrosine kinase and the Ras-Raf-1-MEK-microtubule-associated protein kinase pathway, J. Exp. Med., 181, 1827, 1995.
59. van der Bruggen, T., Caldenhoven, E., Kanters, D., Coffer, P., Raaijmakers, J. A., Lammers, J. W., and Koenderman, L., Interleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and Stat 1 alpha, Blood, 85, 1442, 1995.
60. Pazdrak, K., Stafford, S., and Alam, R., The activation of the Jak-STAT 1 signaling pathway by IL-5 in eosinophils, J. Immunol., 155, 397, 1995.
61. Caldenhoven, E., van Dijk, T., Raaijmakers, J. A., Lammers, J. W., Koenderman, L., and De Groot, R. P., Activation of the STAT3/acute phase response factor transcription factor by interleukin-5, J. Biol. Chem., 270, 25778, 1995.
62. Motojima, S., Frigas, E., Loegering, D. A., and Gleich, G. J., Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro, Am. Rev. Respir. Dis., 139, 801, 1989.
63. Kita, H., Abu Ghazaleh, R. I., Sur, S., and Gleich, G. J., Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils, 154, 4749, 1995.
64. Kita, H., Weiler, D. A., Abu Ghazaleh, R., Sanderson, C. J., and Gleich, G. J., Release of granule proteins from eosinophils cultured with IL-5, J. Immunol., 149, 629, 1992.
65. Fujisawa, T., Abu Ghazaleh, R., Kita, H., Sanderson, C. J., and Gleich, G. J., Regulatory effect of cytokines on eosinophil degranulation, J. Immunol., 144, 642, 1990.
66. Takafuji, S., Tadokoro, K., Ito, K., and Dahinden, C. A., Effects of physiologic soluble agonists on leukotriene C4 production and degranulation by human eosinophils, Int. Arch. Allergy Immunol., 1, 36, 1995.
67. Tai, P. C. and Spry, C. J., The effects of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 on the secretory capacity of human blood eosinophils, Clin. Exp. Immunol., 80, 426, 1990.
68. Carlson, M., Peterson, C., and Venge, P., The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation, Allergy, 48, 437, 1993.
69. Takafuji, S., Bischoff, S. C., De Weck, A. L., and Dahinden, C. A., IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C4 in response to soluble agonists, J. Immunol., 147, 3855, 1991.
70. Owen, W. F., Jr., Petersen, J., and Austen, K. F., Eosinophils altered phenotypically and primed by culture with granulocyte/macrophage colony-stimulating factor and 3T3 fibroblasts generate leukotriene C4 in response to FMLP, J. Clin. Invest., 87, 1958, 1991.
71. 2+ independent and accompanied by induction of tyrosine kinase activity, J. Leukocyte Biol., 53, 347, 1993.
72. Sedgwick, J. B., Quan, S. F., Calhoun, W. J., and Busse, W. W., Effect of interleukin-5 and granulocyte-macrophage colony stimulating factor on in vitro eosinophil function: comparison with airway eosinophils, J. Allergy Clin. Immunol., 96, 375, 1995.
73. Moser, R., Fehr, J., and Bruijnzeel, P. L., IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals, J. Immunol., 149, 1432, 1992.
74. Ebisawa, M., Yamada, T., Bickel, C., Klunk, D., and Schleimer, R. P., Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES, J. Immunol., 153, 2153, 1994.
75. Walsh, G. M., Hartnell, A., Wardlaw, A. J., Kurihara, K., Sanderson, C. J., and Kay, A. B., IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD 11/18)-dependent manner, Immunology, 71, 258, 1990.
76. Wang, J. M., Rambaldi, A., Biondi, A., Chen, Z. G., Sanderson, C. J., and Mantovani, A., Recombinant human interleukin 5 is a selective eosinophil chemoattractant, Eur. J. Immunol., 19, 701, 1989.
77. Sehmi, R., Wardlaw, A. J., Cromwell, O., Kurihara, K., Waltmann, P., and Kay, A. B., Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects, Blood, 79, 2952, 1992.
78. Warringa, R. A., Schweizer, R. C., Maikoe, T., Kuijper, P. H., Bruijnzeel, P. L., and Koendermann, L., Modulation of eosinophil chemotaxis by interleukin-5, Am. J. Respir. Cell. Mol. Biol., 7, 631, 1992.
79. Rothenberg, M. E., Petersen, J., Stevens, R. L., Silberstein, D. S., McKenzie, D. T., Austen, K. F., and Owen, W. F., Jr., IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity, J. Immunol., 143, 2311, 1989.
80. Tai, P. C., Sun, L., and Spry, C. J., Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro, Clin. Exp. Immunol., 85, 312, 1991.
81. Yamaguchi, T., Suda, T., Ohta, S., Tominaga, K., Miura, Y., and Kasahara, T., Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils, Blood, 78, 2542, 1991.
82. Yousefi, S., Green, D. R., Blaser, K., and Simon, H. U., Protein-tyrosine phosphorylation regulates apoptosis in human eosinophils and neutrophils, Proc. Natl. Acad. Sci. U.S.A., 91, 10868, 1994.
83. Moqbel, R., Levi Schaffer, F., and Kay, A. B., Cytokine generation by eosinophils, J. Allergy Clin. Immunol., 94, 1183, 1994.
84. Kita, H., Ohnishi, T., Okubo, Y., Weiler, D., Abrams, J. S., and Gleich, G. J., Granulocyte/ macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils, J. Exp. Med., 174, 745, 1991.
85. Desreumaux, P., Janin, A., Colombel, J. F., Prin, L., Plumas, J., Emilie, D., Torpier, G., Capron, A., and Capron, M., Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease, J. Exp. Med., 175, 293, 1992.
86. Broide, D. H., Paine, M. M., and Firestein, G. S., Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics, J. Clin. Invest., 90, 1414, 1992.
87. Moqbel, R., Hamid, Q., Ying, S., Barkans, J., Hartnell, A., Tsicopoulos, A., Wardlaw, A. J., and Kay, A. B., Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils, J. Exp. Med., 174, 749, 1991.
88. Ohno, I., Lea, R., Finotto, S., Marshall, J., Denburg, J., Dolovich, J., Gauldie, J., and Jordana, M., Granulocyte/macrophage colony-stimulating factor (GM-CSF) gene expression by eosinophils in nasal polyposis, Am. J. Respir. Cell. Mol. Biol., 5, 505, 1991.
89. Weller, P. F., Rand, T. H., Barrett, T., Elovic, A., Wong, D. T., and Finberg, R. W., Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression, J. Immunol., 150, 2554, 1993.
90. Nonaka, M., Nonaka, R., Woolley, K., Adelroth, E., Miura, K., Okhawara, Y., Glibetic, M., Nakano, K., O'Byrne, P., Dolovich, J., and Jordana, M., Distinct immunohistochemical localization of IL-4 in human inflamed airway tissues. IL-4 is localized to eosinophils in vivo and is released by peripheral blood eosinophils, J. Immunol., 155, 3234, 1995.
91. Moqbel, R., Ying, S., Barkans, J., Newman, T. M., Kimmitt, P., Wakelin, M., Taborda Barata, L., Meng, Q., Corrigan, C. J., Durham, S. R., and Kay, A. B., Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product, J. Immunol., 155, 4939, 1995.
92. Hamid, Q., Barkans, J., Meng, Q., Ying, S., Abrams, J. S., Kay, A. B., and Moqbel, R., Human eosinophils synthesize and secrete interleukin-6, in vitro, Blood, 80, 1496, 1992.
93. Costa, J. J., Matossian, K., Resnick, M. B., Beil, W. J., Wong, D. T., Gordon, J. R., Dvorak, A. M., Weller, P. F., and Galli, S. J., Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha, J. Clin. Invest., 91, 2673, 1993.
94. Wong, D. T., Weller, P. F., Galli, S. J., Elovic, A., Rand, T. H., Gallagher, G. T., Chiang, T., Chou, M. Y., Matossian, K., McBride, J., and Todd, R., Human eosinophils express transforming growth factor alpha, J. Exp. Med., 172, 673, 1990.
95. Wong, D. T., Elovic, A., Matossian, K., Nagura, N., McBride, J., Chou, M. Y., Gordon, J. R., Rand, T. H., Galli, S. J., and Weller, P. F., Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1, Blood, 78, 2702, 1991.
96. Ohno, I., Lea, R. G., Flanders, K. C., Clark, D. A., Banwatt, D., Dolovich, J., Denburg, J., Harley, C. B., Gauldie, J., and Jordana, M., Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1), J. Clin. Invest., 89, 1662, 1992.
97. Braun, R. K., Franchini, M., Erard, F., Rihs, S., De Vries, I. J., Blaser, K., Hansel, T. T., and Walker, C., Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium ionophore, Eur. J. Immunol., 23, 956, 1993.
98. Anwar, A. R., Moqbel, R., Walsh, G. M., Kay, A. B., and Wardlaw, A. J., Adhesion to fibronectin prolongs eosinophil survival, J. Exp. Med., 177, 839, 1993.
99. Miyamasu, M., Hirai, K., Takahashi, Y., Iida, M., Yamaguchi, M., Koshino, T., Takaishi, T., Morita, Y., Ohta, K., Kasahara, T., and Ito, K., Chemotactic agonists induce cytokine generation in eosinophils, J. Immunol., 154, 1339, 1995.
100. Miyamasu, M., Misaki, Y., Hirai, K., Izumi, S., Takaishi, T., Matsushima, K., Morita, Y., and Kasahara, T., Eosinophilopoietic factors prime eosinophils for increased IL-8 generation, Allergy, in press.
101. Burgess, A. W., Begley, C. G., Johnson, G. R., Lopez, A. F., Williamson, D. J., Mermod, J. J., Simpson, R. J., Schmitz, A., and DeLamarter, J. F., Purification and properties of bacterially synthesized human granulocyte-macrophage colony stimulating factor, Blood, 69, 43, 1987.
102. Silberstein, D. S., Owen, W. F., Gasson, J. C., DiPersio, J. F., Golde, D. W., Bina, J. C., Soberman, R., Austen, K. F., and David, J. R., Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor, J. Immunol., 137, 3290, 1986.
103. Rothenberg, M. E., Owen, W. F., Jr., Silberstein, D. S., Woods, J., Soberman, R. J., Austen, K. F., and Stevens, R. L., Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3, J. Clin. Invest., 81, 1986, 1988.
104. Nagata, M., Sedgwick, J. B., and Busse, W. W., Differential effects of granulocyte-macrophage colony-stimulating factor on eosinophil and neutrophil superoxide anion generation, J. Immunol., 155, 4948, 1995.
105. Warringa, R. A., Koenderman, L., Kok, P. T., Kreukniet, J., and Bruijnzeel, P. L., Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3, Blood, 77, 2694, 1991.
106. Moser, R., Fehr, J., Olgiati, L., and Bruijnzeel, P. L., Migration of primed human eosinophils across cytokine-activated endothelial cell monolayers, Blood, 79, 2937, 1992.
107. Ebisawa, M., Liu, M. C., Yamada, T., Kato, M., Lichtenstein, L. M., Bochner, B. S., and Schleimer, R. P., Eosinophil transendothelial migration induced by cytokines. II. Potentiation of eosinophil transendothelial migration by eosinophil-active cytokines, J. Immunol., 152, 4590, 1994.
108. Lopez, A. F., Williamson, D. J., Gamble, J. R., Begley, C. G., Harlan, J. M., Klebanoff, S. J., Waltersdorph, A., Wong, G., Clark, S. C., and Vadas, M. A., Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival, J. Clin. Invest., 78, 1220, 1986.
109. Owen, W. F., Jr., Rothenberg, M. E., Silberstein, D. S., Gasson, J. C., Stevens, R. L., Austen, K. F., and Soberman, R. J., Regulation of human eosinophil viability, density, and function by granulocyte/ macrophage colony-stimulating factor in the presence of 3T3 fibroblasts, J. Exp. Med., 166, 129, 1987.
110. Lamas, A. M., Leon, O. G., and Schleimer, R. P., Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor, J. Immunol., 147, 254, 1991.
111. Valent, P., Besemer, J., Sillaber, C., Butterfield, J. H., Eher, R., Majdic, O., Kishi, K., Klepetko, W., Eckersberger, F., Lechner, K., and Bettelheim, P., Failure to detect IL-3 binding sites on human mast cells, J. Immunol., 145, 3432, 1990.
112. Valent, P., Schmidt, G., Besemer, J., Mayer, P., Zenke, G., Liehl, E., Hinterberger, W., Lechner, K., Maurer, D., and Bettelheim, P., Interleukin-3 is a differentiation factor for human basophils, Blood, 73, 1763, 1989.
113. Mayer, P., Valent, P., Schmidt, G., Liehl, E., and Bettelheim, P., The in vivo effects of recombinant human interleukin-3: demonstration of basophil differentiation factor, histamine-producing activity, and priming of GM-CSF-responsive progenitors in non-human primates. Blood, 74, 613, 1989.
114. Ravetch, J. V. and Kinet, J. P., Fc receptors, Annu. Rev. Immunol., 9, 457, 1991.
115. Alber, G., Miller, L., Jelsema, C. L., Varin Blank, N., and Metzger, H., Structure-function relationships in the mast cell high affinity receptor for IgE. Role of the cytoplasmic domains and of the beta subunit, J. Biol. Chem., 266, 22613, 1991.
116. Jouvin, M. H., Adamczewski, M., Numerof, R., Letourneur, O., Valle, A., and Kinet, J. P., Differential control of the tyrosine kinases Lyn and Syk by the two signaling chains of the high affinity immunoglobulin E receptor, J. Biol. Chem., 269, 5918, 1994.
117. Benhamou, M., Gutkind, J. S., Robbins, K. C., and Siraganian, R. P., Tyrosine phosphorylation coupled to IgE receptor-mediated signal transduction and histamine release, Proc. Natl. Acad. Sci. U.S.A., 87, 5327, 1990.
118. Kihara, H. and Siraganian, R. P., Src homology 2 domains of Syk and Lyn bind to tyrosine-phosphorylated subunits of the high affinity IgE receptor, J. Biol. Chem., 269, 22427, 1994.
119. Metzger, H., The receptor with high affinity for IgE, Immunol. Rev., 125, 37, 1992.
120. Haak Frendscho, M., Arai, N., Arai, K., Baeza, M. L., Finn, A., and Kaplan, A. P., Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release, J. Clin. Invest., 82, 17, 1988.
121. Alam, R., Welter, J. B., Forsythe, P. A., Lett Brown, M. A., and Grant, J. A., Comparative effect of recombinant IL-1, -2, -3, -4, and -6, IFN-gamma, granulocyte-macrophage-colony-stimulating factor, tumor necrosis factor-alpha, and histamine-releasing factors on the secretion of histamine from basophils, J. Immunol., 142, 3431, 1989.
122. MacDonald, S. M., Schleimer, R. P., Kagey Sobotka, A., Gillis, S., and Lichtenstein, L. M., Recombinant IL-3 induces histamine release from human basophils, J. Immunol., 142, 3527, 1989.
123. Hirai, K., Monta, Y., Misaki, Y., Ohta, K., Takaishi, T., Suzuki, S., Motoyoshi, K., and Miyamoto, T., Modulation of human basophil histamine release by hemopoietic growth factors, J. Immunol., 141, 3958, 1988.
124. Schleimer, R. P., Derse, C. P., Friedman, B., Gillis, S., Plaut, M., Lichtenstein, L. M., and MacGlashan, D. W., Jr., Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids, J. Immunol., 143, 1310, 1989.
125. Kurimoto, Y., De Week, A. L., and Dahinden, C. A., The effect of interleukin 3 upon IgE-dependent and IgE-independent basophil degranulation and leukotriene generation, Eur. J. Immunol., 21, 361, 1991.
126. O'Donnell, M. C., Ackerman, S. J., Gleich, G. J., and Thomas, L. L., Activation of basophil and mast cell histamine release by eosinophil granule major basic protein, J. Exp. Med., 157, 1981, 1983.
127. Sarmiento, E. U., Espiritu, B. R., Gleich, G. J., and Thomas, L. L., IL-3, IL-5, and granulocyte-macrophage colony-stimulating factor potentiate basophil mediator release stimulated by eosinophil granule major basic protein, J. Immunol., 155, 2211, 1995.
128. Bischoff, S. C., de Weck, A. L., and Dahinden, C. A., Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a, Proc. Natl. Acad. Sci. U.S.A., 87, 6813, 1990.
129. Brunner, T., de Weck, A. L., and Dahinden, C. A., Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5, J. Immunol, 147, 237, 1991.
130. MacGlashan, D. W., Jr. and Hubbard, W. C., IL-3 alters free arachidonic acid generation in C5a-stimulated human basophils, J. Immunol., 151, 6358, 1993.
131. Krieger, M., von Tscharner, V., and Dahinden, C. A., Signal transduction for interleukin-3-dependent leukotriene synthesis in normal human basophils: opposing role of tyrosine kinase and protein kinase, Eur. J. Immunol., 22, 2907, 1992.
132. Yamaguchi, M., Hirai, K., Ohta, K., Suzuki, K., Kitani, S., Takaishi, T., Ito, K., Ra, C., and Monta, Y., Nonreleasing basophils convert to releasing basophils by culturing with interleukin-3, J. Allergy Clin. Immunol., 97, 1279, 1996.
133. Ochensberger, B., Rihs, S., Brunner, T., and Dahinden, C. A., IgE-independent interleukin-4 expression and induction of a late phase of leukotriene C4 formation in human blood basophils, Blood, 86, 4039, 1995.
134. Kurimoto, Y., de Weck, A. L., and Dahinden, C. A., Interleukin 3-dependent mediator release in basophils triggered by C5a, J. Exp. Med., 170, 467, 1989.
135. Yamaguchi, M., Hirai, K., Shoji, S., Takaishi, T., Ohta, K., Morita, Y., Suzuki, S., and Ito, K., Haemopoietic growth factors induce human basophil migration in vitro, Clin. Exp. Allergy, 22, 379, 1992.
136. Tanimoto, Y., Takahashi, K., and Kimura, I., Effects of cytokines on human basophil chemotaxis, Clin. Exp. Allergy, 22, 1020, 1992.
137. Bochner, B. S., McKelvey, A. A., Sterbinsky, S. A., Hildreth, J. E., Derse, C. P., Klunk, D. A., Lichtenstein, L. M., and Schleimer, R. P., IL-3 augments adhesiveness for endothelium and CD11b expression in human basophils but not neutrophils, J. Immunol., 145, 1832, 1990.
138. Yamaguchi, M., Hirai, K., Morita, Y., Takaishi, T., Ohta, K., Suzuki, S., Motoyoshi, K., Kawanami, O., and Ito, K., Hemopoietic growth factors regulate the survival of human basophils in vitro. Int. Arch. Allergy Immunol., 97, 322, 1992.
139. Piccinni, M. P., Macchia, D., Parronchi, P., Giudizi, M. G., Bani, D., Alterini, R., Grossi, A., Ricci, M., Maggi, E., and Romagnani, S., Human bone marrow non-B, non-T cells produce interleukin 4 in response to cross-linkage of Fc epsilon and Fc gamma receptors, Proc. Natl. Acad. Sci. U.S.A., 88, 8656, 1991.
140. Arock, M., Merle Beral, H., Dugas, B., Ouaaz, F., Le Goff, L., Vouldoukis, I., Mencia Huerta, J. M., Schmitt, C., Leblond Missenard, V., Debre, P., and Mossalayi, M. D., IL-4 release by human leukemic and activated normal basophils, J. Immunol., 151, 1441, 1993.
141. Gauchat, J. F., Henchoz, S., Mazzei, G., Aubry, J. P., Brunner, T., Blasey, H., Life, P., Talabot, D., Flores Romo, L., Thompson, J., Kishi, K., Butterfield, J., Dahinden, C., and Bonnefoy, J. Y., Induction of human IgE synthesis in B cells by mast cells and basophils, Nature, 365, 340, 1993.
142. Brunner, T., Heusser, C. H., and Dahinden, C. A., Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation, J. Exp. Med., 177, 605, 1993.
143. MacGlashan, D., Jr., White, J. M., Huang, S. K., Ono, S. J., Schroeder, J. T., and Lichtenstein, L. M., Secretion of IL-4 from human basophils. The relationship between IL-4 mRNA and protein in resting and stimulated basophils, J. Immunol., 152, 3006, 1994.
144. Hirai, K., Yamaguchi, M., Misaki, Y., Takaishi, T., Ohta, K., Morita, Y., Ito, K., and Miyamoto, T., Enhancement of human basophil histamine release by interleukin 5, J. Exp. Med., 172, 1525, 1990.
145. Bischoff, S. C., Brunner, T., De Weck, A. L., and Dahinden, C. A., Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists, J. Exp. Med., 172, 1577, 1990.
146. Valent, P., Spanblochl, E., Sperr, W. R., Sillaber, C., Zsebo, K. M., Agis, H., Strobl, H., Geissler, K., Bettelheim, P., and Lechner, K., Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture, Blood, 80, 2237, 1992.
147. Mitsui, H., Furitsu, T., Dvorak, A. M., Irani, A. M., Schwartz, L. B., Inagaki, N., Takei, M., Ishizaka, K., Zsebo, K. M., Gillis, S., and Ishizaka, T., Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand, Proc. Natl. Acad. Sci. U.S.A., 90, 735, 1993.
148. Bischoff, S. C. and Dahinden, C. A., c-kit ligand: a unique potentiator of mediator release by human lung mast cells, J. Exp. Med., 175, 237, 1992.
149. Takaishi, T., Morita, Y., Hirai, K., Yamaguchi, M., Ohta, K., Noda, E., Morita, T., Ito, K., and Miyamoto, T., Effect of cytokines on mediator release from human dispersed lung mast cells, Allergy, 49, 837, 1994.
150. Columbo, M., Horowitz, E. M., Botana, L. M., MacGlashan, D. W., Jr., Bochner, B. S., Gillis, S., Zsebo, K. M., Galli, S. J., and Lichtenstein, L. M., The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils, J. Immunol., 149, 599, 1992.
151. Kuna, P., Reddigari, S. R., Schall, T. J., Rucinski, D., Sadick, M., and Kaplan, A. P., Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/ chemokine family, J. Immunol., 150, 1932, 1993.
152. Warren, D. J. and Moore, M. A., Synergism among interleukin 1, interleukin 3, and interleukin 5 in the production of eosinophils from primitive hemopoietic stem cells, J. Immunol., 140, 94, 1988.
153. Whiteomb, E. A., Dinarello, C. A., and Pincus, S. H., Differential effects of interleukin-1 alpha and interleukin-1 beta on human peripheral blood eosinophils, Blood, 73, 1904, 1989.
154. Subramanian, N. and Bray, M. A., Interleukin 1 releases histamine from human basophils and mast cells in vitro, J. Immunol., 138, 271, 1987.
155. Haak Frendscho, M., Dinarello, C., and Kaplan, A. P., Recombinant human interleukin-1 beta causes histamine release from human basophils, J. Allergy Clin. Immunol., 82, 218, 1988.
156. Massey, W. A., Randall, T. C., Kagey Sobotka, A., Warner, J. A., MacDonald, S. M., Gillis, S., Allison, A. C., and Lichtenstein, L. M., Recombinant human IL-1 alpha and -1 beta potentiate IgE-mediated histamine release from human basophils, J. Immunol., 143, 1875, 1989.
157. Zeck Kapp, G., Czech, W., and Kapp, A., TNF alpha-induced activation of eosinophil oxidative metabolism and morphology - comparison with IL-5, Exp. Dermatol., 3, 176, 1994.
158. Takafuji, S., Bischoff, S. C., De Weck, A. L., and Dahinden, C. A., Opposing effects of tumor necrosis factor-alpha and nerve growth factor upon leukotriene C4 production by human eosinophils triggered with N-formyl-methionyl-leucyl-phenylalanine, Eur. J. Immunol., 22, 969, 1992.
159. Valerius, T., Repp, R., Kalden, J. R., and Platzer, E., Effects of IFN on human eosinophils in comparison with other cytokines. A novel class of eosinophil activators with delayed onset of action, J. Immunol., 145, 2950, 1990.
160. Wallen, N., Kita, H., Weiler, D., and Gleich, G. J., Glucocorticoids inhibit cytokine-mediated eosinophil survival, J. Immunol., 147, 3490, 1991.
161. Ida, S., Hooks, J. J., Siraganian, R. P., and Notkins, A. L., Enhancement of IgE-mediated histamine release from human basophils by viruses: role of interferon, J. Exp. Med., 145, 892, 1977.
162. Ida, S., Hooks, J. J., Siraganian, R. P., and Notkins, A. L., Enhancement of IgE-mediated histamine release from human basophils by immune-specific lymphokines, Clin. Exp. Immunol., 41, 380, 1980.
163. Lett Brown, M. A., Aelvoet, M., Hooks, J. J., Georgiades, J. A., Thueson, D. O., and Grant, J. A., Enhancement of basophil chemotaxis in vitro by virus-induced interferon, J. Clin. Invest., 67, 547, 1981.
164. Alam, R., Forsythe, P., Stafford, S., and Fukuda, Y., Transforming growth factor beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis, J. Exp. Med., 179, 1041, 1994.
165. Pazdrak, K., Justement, L., and Alam, R., Mechanism of inhibition of eosinophil activation by transforming growth factor-beta. Inhibition of Lyn, MAP, Jak2 kinases and STAT1 nuclear factor, J. Immunol., 155, 4454, 1995.
166. Sillaber, C., Geissler, K., Scherrer, R., Kaltenbrunner, R., Bettelheim, P., Lechner, K., and Valent, P., Type beta transforming growth factors promote interleukin-3 (IL-3)-dependent differentiation of human basophils but inhibit IL-3-dependent differentiation of human eosinophils, Blood, 80, 634, 1992.
167. Hirai, K., Miyamasu, M., Yamaguchi, M., Nakajima, K., Ohtoshi, T., Koshino, T., Takaishi, T., Monta, Y., and Ito, K., Modulation of human basophil histamine release by insulin-like growth factors, J. Immunol., 150, 1503, 1993.
168. Barbacid, M., The Trk family of neurotrophin receptors, J. Neurobiol., 25, 1386, 1994.
169. Otten, U. and Gadient, R. A., Neurotrophins and cytokines - intermediaries between the immune and nervous systems, Int. J. Dev. Neurosci., 13, 147, 1995.
170. Bischoff, S. C. and Dahinden, C. A., Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils, Blood, 79, 2662, 1992.
171. Matsushima, K. and Oppenheim, J. J., Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF, Cytokine, 1, 2, 1989.
172. Larsen, C. G., Anderson, A. O., Appella, E., Oppenheim, J. J., and Matsushima, K., The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes, Science, 243, 1464, 1989.
173. Kimata, H., Yoshida, A., Ishioka, C., Lindley, I., and Mikawa, H., Interleukin 8 (IL-8) selectively inhibits immunoglobulin E production induced by IL-4 in human B cells, J. Exp. Med., 176, 1227, 1992.
174. Collins, P. D., Weg, V. B., Faccioli, L. H., Watson, M. L., Moqbel, R., and Williams, T. J., Eosinophil accumulation induced by human interleukin-8 in the guinea-pig in vivo, Immunology, 79, 312, 1993.
175. Medhurst, A. D., Westwick, J., and Piper, P. J., hrIL-8-induced hyperresponsiveness in guinea pig perfused lungs, Ann. N.Y. Acad. Sci., 629, 419, 1991.
176. Leonard, E. J., Skeel, A., Yoshimura, T., Noer, K., Kutvirt, S., and Van Epps, D., Leukocyte specificity and binding of human neutrophil attractant/activation protein-1, J. Immunol., 144, 1323, 1990.
177. Dahinden, C. A., Kurimoto, Y., De Week, A. L., Lindley, I., Dewald, B., and Baggiolini, M., The neutrophil-activating peptide NAF/NAP-1 induces histamine and leukotriene release by interleukin 3-primed basophils, J. Exp. Med., 170, 1787, 1989.
178. Krieger, M., Brunner, T., Bischoff, S. C., von Tscharner, V., Walz, A., Moser, B., Baggiolini, M., and Dahinden, C. A., Activation of human basophils through the IL-8 receptor, J. Immunol., 149, 2662, 1992.
179. Murphy, P. M. and Tiffany, H. L., Cloning of complementary DNA encoding a functional human interleukin-8 receptor, Science, 253, 1280, 1991.
180. Holmes, W. E., Lee, J., Kuang, W. J., Rice, G. C., and Wood, W. I., Structure and functional expression of a human interleukin-8 receptor, Science, 253, 1278, 1991.
181. Thueson, D. O., Speck, L. S., Lett Brown, M. A., and Grant, J. A., Histamine-releasing activity (HRA). I. Production by mitogen-or antigen-stimulated human mononuclear cells, J. Immunol., 123, 626, 1979.
182. Thueson, D. O., Speck, L. S., Lett Brown, M. A., and Grant, J. A., Histamine-releasing activity (HRA). II. Interaction with basophils and physicochemical characterization, J. Immunol., 123, 633, 1979.
183. Alam, R. and Grant, J. A., The chemokines and the histamine-releasing factors: modulation of function of basophils, mast cells and eosinophils, Chem. Immunol., 61, 148, 1995.
184. Kuna, P., Reddigari, S. R., Schall, T. J., Rucinski, D., Viksman, M. Y., and Kaplan, A. P., RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils, J. Immunol., 149, 636, 1992.
185. Bischoff, S. C., Krieger, M., Brunner, T., Rot, A., von Tscharner, V., Baggiolini, M., and Dahinden, C. A., RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors, Eur. J. Immunol., 23, 761, 1993.
186. Alam, R., Forsythe, P. A., Stafford, S., Lett Brown, M. A., and Grant, J. A., Macrophage inflammatory protein-1 alpha activates basophils and mast cells, J. Exp. Med., 176, 781, 1992.
187. Bischoff, S. C., Krieger, M., Brunner, T., and Dahinden, C. A., Monocyte chemotactic protein 1 is a potent activator of human basophils, J. Exp. Med., 175, 1271, 1992.
188. Kuna, P., Reddigari, S. R., Rucinski, D., Oppenheim, J. J., and Kaplan, A. P., Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils, J. Exp. Med., 175, 489, 1992.
189. Alam, R., Lett Brown, M. A., Forsythe, P. A., Anderson Walters, D. J., Kenamore, C., Kormos, C., and Grant, J. A., Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils, J. Clin. Invest., 89, 723, 1992.
190. Dahinden, C. A., Geiser, T., Brunner, T., von Tscharner, V., Caput, D., Ferrara, P., Minty, A., and Baggiolini, M., Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine, J. Exp. Med., 179, 751, 1994.
191. Alam, R., Forsythe, P., Stafford, S., Heinrich, J., Bravo, R., Proost, P., and Van Damme, J., Monocyte chemotactic protein-2, monocyte chemotactic protein-3, and fibroblast-induced cytokine. Three new chemokines induce chemotaxis and activation of basophils, J. Immunol., 153, 3155, 1994.
192. Rot, A., Krieger, M., Brunner, T., Bischoff, S. C., Schall, T. J., and Dahinden, C. A., RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes, J. Exp. Med., 176, 1489, 1992.
193. Alam, R., Stafford, S., Forsythe, P., Harrison, R., Faubion, D., Lett Brown, M. A., and Grant, J. A., RANTES is a chemotactic and activating factor for human eosinophils, J. Immunol., 150, 3442, 1993.
194. Weber, M., Uguccioni, M., Ochensberger, B., Baggiolini, M., Clark Lewis, I., and Dahinden, C. A., Monocyte chemotactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3, J. Immunol., 154, 4166, 1995.
195. Jose, P. J., Griffiths Johnson, D. A., Collins, P. D., Walsh, D. T., Moqbel, R., Totty, N. F., Truong, O., Hsuan, J. J., and Williams, T. J., Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation, J. Exp. Med., 179, 881, 1994.
196. Ponath, P. D., Qin, S., Ringler, D. J., Clark-Lewis, I., Wang, J., Kassam, N., Smith, H., Shi, X., Gonzaro, J.-A., Newman, W., Guttierrez-Ramos, J.-C., and Mackay, C. R., Cloning of the human eosinophil chemoattractant, eotaxin, J. Clin. Invest., 97, 604, 1996.
197. Baggiolini, M. and Dahinden, C. A., CC chemokines in allergic inflammation, Immunol. Today, 15, 127, 1994.
198. Gao, J. L., Kuhns, D. B., Tiffany, H. L., McDermott, D., Li, X., Francke, U., and Murphy, P. M., Structure and functional expression of the human macrophage inflammatory protein 1 alpha/RANTES receptor, J. Exp. Med., 177, 1421, 1993.
199. Neote, K., DiGregorio, D., Mak, J. Y., Horuk, R., and Schall, T. J., Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor, Cell, 72, 415, 1993.
200. Combadiere, C., Ahuja, S. K., Van Damme, J., Tiffany, H. L., Gao, J. L., and Murphy, P. M., Monocyte chemoattractant protein-3 is functional ligand for CC chemokine receptors 1 and 2B, J. Biol. Chem., 270, 29671, 1995.
201. Charo, I. F., Myers, S. J., Herman, A., Franci, C., Connolly, A. J., and Coughlin, S. R., Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails, Proc. Natl. Acad. Sci. U.S.A., 91, 2752, 1994.
202. Combadiere, C., Ahuja, S. K., and Murphy, P. M., Cloning and functional expression of a human eosinophil CC chemokine receptor, J. Biol. Chem., 270, 16491, 1995.
203. Daugherty, B. L., Siciliano, S. J., DeMartino, J. A., Malkowitz, L., Sirotina, A., and Springer, M. S., Cloning, expression, and characterization of the human eosinophil eotaxin receptor, J. Exp. Med., 183, 2349, 1996.
204. Power, C. A., Meyer, A., Nemeth, K., Bacon, K. B., Hoogewerf, A. J., Proudfoot, A. E., and Wells, T. N., Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line, J. Biol. Chem., 270, 19495, 1995.
205. Wardlaw, A. J., Walsh, G. M., and Symon, F. A., Mechanisms of eosinophil and basophil migration, Allergy, 49, 797, 1994.
206. Bochner, B. A., Peachell, P. T., Brown, K. E., and Schleimer, R. P., Adherence of human basophils to cultured umbilical vein endothelial cells, J. Clin. Invest., 81, 1355, 1988.
207. Ebisawa, M., Bochner, B. S., Georas, S. N., and Schleimer, R. P., Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1 beta-induced transendo-thelial migration, J. Immunol., 149, 4021, 1992.
208. Bochner, B. S., Luscinskas, F. W., Gimbrone, M. A., Jr., Newman, W., Sterbinsky, S. A., Derse Anthony, C. P., Klunk, D., and Schleimer, R. P., Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules, J. Exp. Med., 173, 1553, 1991.
209. Dobrina, A., Menegazzi, R., Carlos, T. M., Nardon, E., Cramer, R., Zacchi, T., Harlan, J. M., and Patriarca, P., Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to the cytokine-induced ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor, J. Clin. Invest., 88, 20, 1991.
210. Clark, E. A. and Brugge, J. S., Integrins and signal transduction pathways: the road taken, Science, 268, 233, 1995.
211. Horie, S. and Kita, H., CD11b/CD 18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor, J. Immunol., 152, 5457, 1994.
212. Kaneko, M., Horie, S., Kato, M., Gleich, G. J., and Kita, H., A crucial role for beta 2 integrin in the activation of eosinophils stimulated by IgG, J. Immunol., 155, 2631, 1995.
213. Nagata, M., Sedgwick, J. B., Bates, M. E., Kita, H., and Busse, W. W., Eosinophil adhesion to vascular cell adhesion molecule-1 activates superoxide anion generation, J. Immunol., 155, 2194, 1995.
214. Nojima, Y., Rothstein, D. M., Sugita, K., Schlossman, S. F., and Morimoto, C., Ligation of VLA-4 on T cells stimulates tyrosine phosphorylation of a 105-kD protein, J. Exp. Med., 175, 1045, 1992.
215. Anwar, A. R., Walsh, G. M., Cromwell, O., Kay, A. B., and Wardlaw, A. J., Adhesion to fibronectin primes eosinophils via alpha 4 beta 1 (VLA-4), Immunology, 82, 222, 1994.
216. Godding, V., Stark, J. M., Sedgwick, J. B., and Busse, W. W., Adhesion of activated eosinophils to respiratory epithelial cells is enhanced by tumor necrosis factor-alpha and interleukin-1 beta, Am. J. Respir. Cell. Mol. Biol., 13, 555, 1995.
217. Neeley, S. P., Hamann, K. J., Dowling, T. L., McAllister, K. T., White, S. R., and Leff, A. R., Augmentation of stimulated eosinophil degranulation by VLA-4 (CD49d)-mediated adhesion to fibronectin, Am. J. Respir. Cell. Mol. Biol., 11, 206, 1994.
218. Thomas, L. L. and Lictenstein, L. M., Augmentation of antigen-stimulated histamine release from human basophils by serum-treated zymosan particles. I. Characteristics of enhancement, J. Immunol., 123, 1462, 1979.
219. Calhoun, W. J., Swenson, C. A., Dick, E. C., Schwartz, L. B., Lemanske, R. F., Jr., and Busse, W. W., Experimental rhinovinis 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects, Am. Rev. Respir. Dis., 144, 1267, 1991.
220. Peterson, A. P., Altman, L. C., Hill, J. S., Gosney, K., and Kadin, M. E., Glucocorticoid receptors in normal human eosinophils: comparison with neutrephils, J. Allergy Clin. Immunol., 68, 212, 1981.
221. Schule, R., Rangarajan, P., Kliewer. S., Ransone, L. J., Bolado, J., Yang, N., Verma, I. M., and Evans, R. M., Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor, Cell, 62, 1217, 1990.
222. Yang Yen, H. F., Chambard, J. C., Sun, Y. L., Smeal, T., Schmidt, T. J., Drouin, J., and Karin, M., Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction, Cell, 62, 1205, 1990.
223. Jonat, C., Rahmsdorf, H. J., Park, K. K., Cato, A. C., Gebel, S., Ponta, H., and Herrlich, P., Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone, Cell, 62, 1189, 1990.
224. Hocke, G. M., Barry, D., and Fey, G. H., Synergistic action of interleukin-6 and glucocorticoids is mediated by the interleukin-6 response element of the rat alpha 2 macroglobulin gene, Mol. Cell. Biol., 12, 2282, 1992.
225. Mukaida, N., Morita, M., Ishikawa, Y., Rice, N., Okamoto, S., Kasahara, T., and Matsushima, K., Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression, J. Biol. Chem., 269, 13289, 1994.
226. Vacca, A., Felli, M. P., Farina, A. R., Martinotti, S., Maroder, M., Screpanti, I., Meco, D., Petrangeli, E., Frati, L., and Gulino, A., Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements, J. Exp. Med., 175, 637, 1992.
227. Kawabori, S., Soda, K., Perdue, M. H., and Bienenstock, J., The dynamics of intestinal eosinophil depletion in rats treated with dexamethasone, Lab. Invest., 64, 224, 1991.
228. Hallam, C., Pritchard, D. I., Trigg, S., and Eady, R. P., Rat eosinophil-mediated antibody-dependent cellular cytotoxicity: investigations of the mechanisms of target cell lysis and inhibition by glucocorticoids, Clin. Exp. Immunol., 48, 641, 1982.
229. Kita, H., Abu Ghazaleh, R., Sanderson, C. J., and Gleich, G. J., Effect of steroids on immunoglobulin-induced eosinophil degranulation, J. Allergy Clin. Immunol., 87, 70, 1991.
230. Altman, L. C., Hill, J. S., Hairfield, W. M., and Mullarkey, M. F., Effects of corticosteroids on eosinophil chemotaxis and adherence, J. Clin. Invest., 67, 28, 1981.
231. Kaiser, J., Bickel, C. A., Bochner, B. S., and Schleimer, R. P., The effects of the potent glucocorticoid budesonide on adhesion of eosinophils to human vascular endothelial cells and on endothelial expression of adhesion molecules, J. Pharmacol. Exp. Ther., 267, 245, 1993.
232. Schleimer, R. P., Schulman, E. S., MacGlashan, D. W., Jr., Peters, S. P., Hayes, E. C., Adams, G. K. D., Lichtenstein, L. M., and Adkinson, N. F., Jr., Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells, J. Clin. Invest., 71, 1830, 1983.
233. Schleimer, R. P., Lichtenstein, L. M., and Gillespie, E., Inhibition of basophil histamine release by anti-inflammatory steroids, Nature, 292, 454, 1981.
234. Schleimer, R. P., MacGlashan, D. W., Jr., Gillespie, E., and Lichtenstein, L. M., Inhibition of basophil histamine release by anti-inflammatory steroids. II. Studies on the mechanism of action, J. Immunol., 129, 1632, 1982.
235. Hirai, K. and Miyamasu, M., unpublished observation.
236. Yamaguchi, M., Hirai, K., Nakajima, K., Ohtoshi, T., Takaishi, T., Ohta, K., Morita, Y., and Ito, K., Dexamethasone inhibits basophil migration, Allergy, 49, 371, 1994.
237. Alexander, A. G., Barnes, N. C., and Kay, A. B., Trial of cyclosporin in corticosteroid-dependent chronic severe asthma [see comments], Lancet, 339, 324, 1992.
238. Stellato, C., de Paulis, A., Ciccarelli, A., Cirillo, R., Patella, V., Casolaro, V., and Marone, G., Anti-inflammatory effect of cyclosporin A on human skin mast cells, J. Invest. Dermatol., 98, 800, 1992.
239. Pedersen, C., Permin, H., Stahl Skov, P., Norn, S., Svenson, M., Mosbech, H., and Bendtzen, K., Inhibitory effect of cyclosporin A on histamine release from human leukocytes and rat mast cells. Allergy, 40, 103, 1985.
240. Ezeamuzie, C. I. and Assem, E. S., Anti-allergic properties of cyclosporin A: inhibition of mediator release from human basophils and rat basophilic leukemia cells (RBL-2H3), Immunopharmacology, 20, 31, 1990.
241. Cirillo, R., Triggiani, M., Siri, L., Ciccarelli, A., Pettit, G. R., Condorelli, M., and Marone, G., Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin, J. Immunol., 144, 3891, 1990.
242. Casolaro, V., Spadaro, G., Patella, V., and Marone, G., In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils, J. Immunol., 151, 5563, 1993.
243. de Paulis, A., Cirillo, R., Ciccarelli, A., Condorelli, M., and Marone, G., FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells, J. Immunol., 146, 2374, 1991.
244. Marone, G., Thomas, L. L., and Lichtenstein, L. M., The role of agonists that activate adenylate cyclase in the control of cAMP metabolism and enzyme release by human polymorphonuclear leukocytes, J. Immunol., 125, 2277, 1980.
245. Toll, J. B. and Andersson, R. G., Effects of enprofylline and theophylline on purified human basophils, Allergy, 39, 515, 1984.
246. Peachell, P. T., Undem, B. J., Schleimer, R. P., MacGlashan, D. W., Jr., Lichtenstein, L. M., Cieslinski, L. B., and Torphy, T. J., Preliminary identification and role of phosphodiesterase isozymes in human basophils, J. Immunol., 148, 2503, 1992.
247. Bourne, H. R., Lichtenstein, L. M., Melmon, K. L., Henney, C. S., Weinstein, Y., and Shearer, G. M., Modulation of inflammation and immunity by cyclin AMP, Science, 184, 19, 1974.
248. Morita, Y. and Miyamoto, T., Fenoterol, a selective beta 2-adrenergic agonist, and inhibition of IgE-mediated basophil histamine release, Allergy, 42, 524, 1987.
249. Kita, H., Abu Ghazaleh, R. I., Gleich, G. J., and Abraham, R. T., Regulation of Ig-induced eosinophil degranulation by adenosine 3′,5′-cyclic monophosphate, J. Immunol., 146, 2712, 1991.
250. Ohta, K., Sawamoto, S., Nakajima, M., Kubota, S., Tanaka, Y., Miyasaka, T., Nagai, A., Hirai, K., Mano, K., and Miyashita, H., The prolonged survival of human eosinophils with interleukin-5 and its inhibition by theophylline via apoptosis, Clin. Exp. Allergy, 26 (suppl. 2), 10, 1996.
251. Heumann, D., Gallay, P., Barras, C., Zaech, P., Ulevitch, R. J., Tobias, P. S., Glauser, M. P., and Baumgartner, J. D., Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes, J. Immunol., 148, 3505, 1992.
252. Stefanova, I., Horejsi, V., Ansotegui, I. J., Knapp, W., and Stockinger, H., GPI-anchored cell-surface molecules complexed to protein tyrosine kinases, Science, 254, 1016, 1991.
253. Weinstein, S. L., June, C. H., and DeFranco, A. L., Lipopolysaccharide-induced protein tyrosine phosphorylation in human macrophages is mediated by CD 14, J. Immunol., 151, 3829, 1993.
254. Terstappen, L. W., Hollander, Z., Meiners, H., and Loken, M. R., Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells, J. Leukocyte Biol., 48, 138, 1990.
255. Norn, S., Baek, L., Jensen, C., Skov, P. S., Permin, H., Jarlov, J. O., and Koch, C., Influence of bacterial endotoxins on basophil histamine release. Potentiation of antigen- and bacteria-induced histamine release, Allergy, 41, 125, 1986.
256. Iida, M., Hirai, K., Shinohara, S., Yamaguchi, M., Takaishi, T., Sakamoto, Y., Ito, K., and Morita, Y., Lipopolysaccharide primes human basophils for enhanced mediator release: requirement for plasma cofactor and CD 14, Biochem. Biophys. Res. Commun., 203, 1295, 1994.
257. Hamid, Q., Springall, D. R., Riveros Moreno, V., Chanez, P., Howarth, P., Redington, A., Bousquet, J., Godard, P., Holgate, S., and Polak, J. M., Induction of nitric oxide synthase in asthma. Lancet, 342, 1510, 1993.
258. Kharitonov, S. A., Yates, D., Robbins, R. A., Logan Sinclair, R., Shinebourne, E. A., and Barnes, P. J., Increased nitric oxide in exhaled air of asthmatic patients, Lancet, 343, 133, 1994.
259. Barnes, P. J. and Liew, F. Y., Nitric oxide and asthmatic inflammation, Immunol. Today, 16, 128, 1995.
260. Beauvais, F., Michel, L., and Dubertret, L., The nitric oxide donors, azide and hydroxylamine, inhibit the programmed cell death of cytokine-deprived human eosinophils, FEBS Lett., 361, 229, 1995.
261. Arock, M., Le Goff, L., Becherel, P. A., Dugas, B., Debre, P., and Mossalayi, M. D., Involvement of Fc epsilon RII/CD23 and L-arginine dependent pathway in IgE-mediated activation of human eosinophils, Biochem. Biophys. Res. Commun., 203, 265, 1994.